Patent · US Active

Selective BACE1 inhibitors

US10011610B2 · kind B2 · utility

0Cited by
12References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 2016
Grant dateJul 3, 2018
Priority date—
Expiry dateSep 22, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C309/31
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.